Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
AIDS Patient Care STDS. 2009 Nov;23(11):939-47. doi: 10.1089/apc.2009.0121.

The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV.

Collaborators (223)

Minglana F, Paul ME, Jackson CD, Rathore MH, Khayat A, Champion K, Cusic S, Yogev R, Chadwick E, Febo-Rodriguez I, Nieves S, Purswani M, Baksi S, Stuard E, Dummit M, Acevedo M, Gonzalez M, Fabregas L, Texidor ME, Scott GB, Mitchell CD, Taybo L, Willumsen S, Bettica L, Amour J, Dashefsky B, Oleske J, Silio M, Alchediak T, Boe C, Cowie M, Spector SA, Viani R, Caffery M, Proctor L, Rana S, Darbari D, Roa JC, Yu PH, Donovan M, Serrano R, Burey M, Auguste R, Chen J, Foster J, Stechenberg BW, Fisher DJ, Johnston AM, Toye M, Homans J, Neely M, Spencer LS, Kovacs A, Burchett S, Karthas N, Moore E, Cromer C, Flynn PM, Patel N, Donohoe M, Jones S, Borkowsky W, Chandwani S, Deygoo N, Akleh S, Handelsman E, Moallem HJ, Swindell DM, Kaye JM, Higgins A, Foca M, LaRussa P, Gershon A, Rutstein RM, Vincent CA, Douglas SD, Koutsoubis GA, Petru A, Courville T, Wara D, Trevithick D, McFarland E, Salbenblatt C, Hutton N, Griffith B, Joyner M, Kiefner C, Acker M, Croteau R, McLellan C, Mohan K, Bamji M, Pathak I, Manwani S, Patel E, Spiegel H, Amos V, Luzuriaga K, Sharples A, Pass R, Crain M, Farley J, Klipner K, Bonagura VR, Schuval SJ, Colter C, Campbell L, Pelton SI, Reagan AM, Rich KC, Hayani K, Bicchinella M, Nachman S, Ferraro D, Madjar S, Puga A, Wiley F, Whitfield K, Johnson O, Dizney R, Champion S, Frere M, DiGrado M, Abrams EJ, Martinez J, Mancao M, Salazar J, Karas G, Belho T, Pitkin B, Eddleman J, Figueroa W, Reyes E, Weiner LB, Contello KA, Holz WA, Famiglietti MJ, Lew J, Delany C, Duff C, Fernandez AD, Hughes PA, Wade N, Adams ME, Piatt JP, Foti J, Clarke-Steffen L, Sleasman J, Delaney C, Mani CS, Andiman WA, Romano S, Hurst L, de Jesus J, Wilson G, Weinberg GA, Gigliotti F, Murante B, Laverty S, Hutchcon N, Townley A, Nesheim S, Dennis R, Emmanuel P, Lujan-Zilberman J, Graisberry C, Moore S, Fisher RG, Cunnion KM, Rubio TT, Sandifer D, Johnson GM, Gay H, Sadler S, Keller M, Hayes J, Gagajena A, Mink C, Johnson D, Church J, Dunaway T, Salata C, Deveikis A, Melton L, Gaur S, Whitley-Williams P, Malhotra A, Cerracchio L, Dolan M, D'Agostino J, Posada R, Mani C, Cobb S, Lavoie SR, Smith TY, Feingold A, Burrows-Clark S, Mrus J, Beiting R, Brady M, Hunkler J, Koranyi K, Albritton W, Warford R, Arpadi S, Gershon A, Miller P, Rubinstein A, Krienik G, Kovacs A, Operskalski E, Wara D, Kamrin A, Farrales S, Johan-Liang R, O'Keefe K, McGann KA, Pickering L, Storch GA, Pahwa S, Rodriquez L, Lewis P, Croteau R.

Author information

  • 1Department of Psychiatry, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Abstract

Second-generation antipsychotics (SGAs) are increasingly prescribed to treat psychiatric symptoms in pediatric patients infected with HIV. We examined the relationship between prescribed SGAs and physical growth in a cohort of youth with perinatally acquired HIV-1 infection. Pediatric AIDS Clinical Trials Group (PACTG), Protocol 219C (P219C), a multicenter, longitudinal observational study of children and adolescents perinatally exposed to HIV, was conducted from September 2000 until May 2007. The analysis included P219C participants who were perinatally HIV-infected, 3-18 years old, prescribed first SGA for at least 1 month, and had available baseline data prior to starting first SGA. Each participant prescribed an SGA was matched (based on gender, age, Tanner stage, baseline body mass index [BMI] z score) with 1-3 controls without antipsychotic prescriptions. The main outcomes were short-term (approximately 6 months) and long-term (approximately 2 years) changes in BMI z scores from baseline. There were 236 participants in the short-term and 198 in the long-term analysis. In linear regression models, youth with SGA prescriptions had increased BMI z scores relative to youth without antipsychotic prescriptions, for all SGAs (short-term increase = 0.192, p = 0.003; long-term increase = 0.350, p < 0.001), and for risperidone alone (short-term = 0.239, p = 0.002; long-term = 0.360, p = 0.001). Participants receiving both protease inhibitors (PIs) and SGAs showed especially large increases. These findings suggest that growth should be carefully monitored in youth with perinatally acquired HIV who are prescribed SGAs. Future research should investigate the interaction between PIs and SGAs in children and adolescents with perinatally acquired HIV infection.

PMID:
19827949
[PubMed - indexed for MEDLINE]
PMCID:
PMC2832650
Free PMC Article

Images from this publication.See all images (2)Free text

FIG. 1.
FIG. 2.
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Mary Ann Liebert, Inc. Icon for PubMed Central
    Loading ...
    Write to the Help Desk